Colorectal Cancer Screening Test (iFOBT)
Colorectal cancer is one of the most common cancers in Germany, with over 50,000 new cases diagnosed each year—around 24,600 in women and 29,900 in men. Early diagnosis is crucial, as outcomes can be significantly improved through preventive screenings like the immunological fecal occult blood test (iFOBT). The iFOBT checks for hidden blood in the stool, which can reveal early stages of colorectal cancer. Detecting these early signs allows for timely treatment, often before symptoms appear, and reduces the risk of severe disease progression.
Hemoglobin
Product information
How to guide
Fast & discrete delivery
Medical assessment
Reliable & accurate results
All you need for testing
Fast & discrete delivery
Medical assessment
Reliable & accurate results
All you need for testing
Fast & discrete delivery
Medical assessment
Reliable & accurate results
All you need for testing
Why should i get tested?
What is iFOBT?
The immunological fecal occult blood test (iFOBT) is a simple, non-invasive test to detect early signs of colorectal cancer by checking for hidden blood in the stool, which may indicate tumors or polyps. If blood is found, a colonoscopy can provide further clarity.
Why is prevention important?
Regular screening and early detection are crucial for catching colorectal cancer at an early, treatable stage. Early intervention greatly improves outcomes, especially since colorectal cancer often develops slowly over time.
Who should get tested
Men and women, especially those over a certain age or with a family history of colorectal cancer, should consider regular screening. Early detection helps identify issues like polyps before they develop into serious conditions.
FAQ
REMI analyzes your samples under the highest German laboratory standards (RiliBÄK criteria) and delivers your results with the utmost accuracy.
Validated Lab Results
Bewertungen
4.8
43%
